47245-6
HIV treatment form Document
Active
Term Description
The collection of specific observations that are valid when passing summary HIV and ART information as defined by the WHO Monitoring Guidelines
Source: Regenstrief LOINC
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
47245-6 | HIV treatment form Document | |||
Indent47246-4 | HIV Antiretroviral therapy Demographic information section | |||
Indent Indent45394-4 | Patient Last (Family) name | |||
Indent Indent45392-8 | Patient First (Given) name | |||
Indent Indent46098-0 | Gender | |||
Indent Indent21112-8 | Birth date | {mm/dd/yyyy} | ||
Indent Indent42077-8 | Patient phone number | |||
Indent Indent13499-9 | HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot | |||
Indent Indent31073-0 | HIV 2 Ab band pattern [Interpretation] in Serum by Immunoblot | |||
Indent47249-8 | HIV Antiretroviral therapy HIV care and family status section | |||
Indent Indent45250-8 | HIV confirmation facility Address | |||
Indent Indent45251-6 | HIV confirmation facility | |||
Indent Indent45252-4 | Institutional entry point HIV treatment | |||
Indent Indent45230-0 | District where patient entered HIV treatment | |||
Indent47248-0 | HIV Antiretroviral therapy Antiretroviral therapy status section | |||
Indent Indent45231-8 | HIV treatment prior to enrollment | |||
Indent Indent47240-7 | Date determined medically eligible to start HIV treatment | |||
Indent Indent45232-6 | Reason medically eligible for HIV treatment | |||
Indent Indent45233-4 | World Health Organization HIV stage | |||
Indent Indent32516-7 | CD3+CD4+ (T4 helper) cells/100 cells in Specimen | % | ||
Indent Indent32515-9 | CD3+CD4+ (T4 helper) cells [#/volume] in Specimen | /uL | ||
Indent Indent47241-5 | Date determined medically eligible and ready to start HIV treatment | |||
Indent Indent45234-2 | Date eligible and selected to start HIV treatment | |||
Indent Indent45253-2 | HIV treatment prior clinic transferred from Address | |||
Indent Indent45254-0 | HIV treatment prior clinic transferred from | |||
Indent Indent45235-9 | Date original clinic HIV treatment start | |||
Indent Indent45236-7 | HIV treatment cohort | |||
Indent Indent8671-0 | History of Functional status | |||
Indent Indent18833-4 | First Body weight | 0..* | kg;[lb_av] | |
Indent Indent3137-7 | Body height Measured | [in_us];cm;m | ||
Indent Indent45257-3 | Date dropped from HIV treatment | |||
Indent Indent31211-6 | Date of death | |||
Indent47247-2 | HIV Antiretroviral therapy Outpatient encounter-level information section | |||
Indent Indent39161-5 | Date next screen visit CPHS | 0..* | ||
Indent Indent45239-1 | Current HIV treatment therapy duration | mo;d | ||
Indent Indent8671-0 | History of Functional status | |||
Indent Indent45233-4 | World Health Organization HIV stage | |||
Indent Indent18833-4 | First Body weight | 0..* | kg;[lb_av] | |
Indent Indent3137-7 | Body height Measured | [in_us];cm;m | ||
Indent Indent45241-7 | Tuberculosis status | |||
Indent Indent45242-5 | Tuberculosis treatment start date | |||
Indent Indent11449-6 | Pregnancy status - Reported | |||
Indent Indent28512-2 | Family Planning Status Family [OMAHA] | |||
Indent Indent8659-5 | Birth control method - Reported | |||
Indent Indent39267-0 | Reason for follow-up (referred to) provider /specialist CPHS | 0..* | ||
Indent Indent39269-6 | Follow-up (referred to) provider /specialist, provider type CPHS | 0..* | ||
Indent Indent39270-4 | Follow-up (referred to) provider /specialist, address CPHS | 0..* | ||
Indent Indent47242-3 | Medication or other side effects associated with HIV treatment | |||
Indent Indent47243-1 | Severity of side effect to HIV treatment | |||
Indent Indent45243-3 | Reason for discontinuation of anti-infective phrophylaxis medication | |||
Indent Indent45247-4 | Reason for missing HIV treatment administration schedule | |||
Indent Indent45248-2 | Number of hospital days since last outpatient visit - Reported | {#} |
Fully-Specified Name
- Component
- HIV Rx Form
- Property
- -
- Time
- Pt
- System
- Form
- Scale
- Doc
- Method
Additional Names
- Short Name
- HIV Rx Form Doc
Basic Attributes
- Class
- PANEL.ART
- Type
- Clinical
- First Released
- Version 2.22
- Last Updated
- Version 2.67
- Order vs. Observation
- Order
- Panel Type
- Panel
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=47245-6 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/47245-6
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright